252 related articles for article (PubMed ID: 30453390)
1. PPARβ/δ-agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1ΔE9 astrocytes.
Konttinen H; Gureviciene I; Oksanen M; Grubman A; Loppi S; Huuskonen MT; Korhonen P; Lampinen R; Keuters M; Belaya I; Tanila H; Kanninen KM; Goldsteins G; Landreth G; Koistinaho J; Malm T
Glia; 2019 Jan; 67(1):146-159. PubMed ID: 30453390
[TBL] [Abstract][Full Text] [Related]
2. PPARβ/δ activation protects against corticosterone-induced ER stress in astrocytes by inhibiting the CpG hypermethylation of microRNA-181a.
Ji J; Zeng XN; Cao LL; Zhang L; Zhao Z; Yang DD; Sun XL
Neuropharmacology; 2017 Feb; 113(Pt A):396-406. PubMed ID: 27789312
[TBL] [Abstract][Full Text] [Related]
3. Context-dependent regulation of endothelial cell metabolism: differential effects of the PPARβ/δ agonist GW0742 and VEGF-A.
Faulkner A; Lynam E; Purcell R; Jones C; Lopez C; Board M; Wagner KD; Wagner N; Carr C; Wheeler-Jones C
Sci Rep; 2020 May; 10(1):7849. PubMed ID: 32398728
[TBL] [Abstract][Full Text] [Related]
4. Gene Doping with Peroxisome-Proliferator-Activated Receptor Beta/Delta Agonists Alters Immunity but Exercise Training Mitigates the Detection of Effects in Blood Samples.
Sibille B; Mothe-Satney I; Le Menn G; Lepouse D; Le Garf S; Baudoin E; Murdaca J; Moratal C; Lamghari N; Chinetti G; Neels JG; Rousseau AS
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768927
[TBL] [Abstract][Full Text] [Related]
5. Carnitine palmitoyltransferase-1 up-regulation by PPAR-β/δ prevents lipid-induced endothelial dysfunction.
Toral M; Romero M; Jiménez R; Mahmoud AM; Barroso E; Gómez-Guzmán M; Sánchez M; Cogolludo Á; García-Redondo AB; Briones AM; Vázquez-Carrera M; Pérez-Vizcaíno F; Duarte J
Clin Sci (Lond); 2015 Nov; 129(9):823-37. PubMed ID: 26253087
[TBL] [Abstract][Full Text] [Related]
6. The PPARβ/δ Agonist GW0742 Induces Early Neuronal Maturation of Cortical Post-Mitotic Neurons: Role of PPARβ/δ in Neuronal Maturation.
Benedetti E; Di Loreto S; D'Angelo B; Cristiano L; d'Angelo M; Antonosante A; Fidoamore A; Golini R; Cinque B; Cifone MG; Ippoliti R; Giordano A; Cimini A
J Cell Physiol; 2016 Mar; 231(3):597-606. PubMed ID: 26206209
[TBL] [Abstract][Full Text] [Related]
7. Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
Bility MT; Zhu B; Kang BH; Gonzalez FJ; Peters JM
Toxicol Sci; 2010 Jan; 113(1):27-36. PubMed ID: 19748995
[TBL] [Abstract][Full Text] [Related]
8. Human Endometrial Stromal Cell Differentiation is Stimulated by PPARβ/δ Activation: New Targets for Infertility?
Yu J; Berga SL; Zou W; Rajakumar A; Man M; Sidell N; Taylor RN
J Clin Endocrinol Metab; 2020 Sep; 105(9):2983-95. PubMed ID: 32594141
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
Sheng L; Ye P; Liu YX; Han CG; Zhang ZY
Clin Exp Hypertens; 2008 Feb; 30(2):109-19. PubMed ID: 18293166
[TBL] [Abstract][Full Text] [Related]
10. Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats.
Quintela AM; Jiménez R; Gómez-Guzmán M; Zarzuelo MJ; Galindo P; Sánchez M; Vargas F; Cogolludo A; Tamargo J; Pérez-Vizcaíno F; Duarte J
Free Radic Biol Med; 2012 Aug; 53(4):730-41. PubMed ID: 22683600
[TBL] [Abstract][Full Text] [Related]
11. PPAR-β/δ activation promotes phospholipid transfer protein expression.
Chehaibi K; Cedó L; Metso J; Palomer X; Santos D; Quesada H; Naceur Slimane M; Wahli W; Julve J; Vázquez-Carrera M; Jauhiainen M; Blanco-Vaca F; Escolà-Gil JC
Biochem Pharmacol; 2015 Mar; 94(2):101-8. PubMed ID: 25662586
[TBL] [Abstract][Full Text] [Related]
12. Short-term activation of peroxysome proliferator-activated receptor beta/delta increases fatty acid oxidation but does not restore insulin action in muscle cells from type 2 diabetic patients.
Debard C; Cozzone D; Ricard N; Vouillarmet J; Disse E; Husson B; Laville M; Vidal H
J Mol Med (Berl); 2006 Sep; 84(9):747-52. PubMed ID: 16897074
[TBL] [Abstract][Full Text] [Related]
13. Complementary Immunometabolic Effects of Exercise and PPARβ/δ Agonist in the Context of Diet-Induced Weight Loss in Obese Female Mice.
Le Garf S; Murdaca J; Mothe-Satney I; Sibille B; Le Menn G; Chinetti G; Neels JG; Rousseau AS
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635041
[TBL] [Abstract][Full Text] [Related]
14. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.
Borland MG; Foreman JE; Girroir EE; Zolfaghari R; Sharma AK; Amin S; Gonzalez FJ; Ross AC; Peters JM
Mol Pharmacol; 2008 Nov; 74(5):1429-42. PubMed ID: 18687807
[TBL] [Abstract][Full Text] [Related]
15. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes.
Burdick AD; Bility MT; Girroir EE; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Cell Signal; 2007 Jun; 19(6):1163-71. PubMed ID: 17254750
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological activation of PPARβ/δ preserves mitochondrial respiratory function in ischemia/reperfusion
Papatheodorou I; Makrecka-Kuka M; Kuka J; Liepinsh E; Dambrova M; Lazou A
Front Endocrinol (Lausanne); 2022; 13():941822. PubMed ID: 36046786
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary Administration of GW0742, a High-Affinity Peroxisome Proliferator-Activated Receptor Agonist, Repairs Collapsed Alveoli in an Elastase-Induced Mouse Model of Emphysema.
Ozawa C; Horiguchi M; Akita T; Oiso Y; Abe K; Motomura T; Yamashita C
Biol Pharm Bull; 2016; 39(5):778-85. PubMed ID: 27150147
[TBL] [Abstract][Full Text] [Related]
18. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.
Hollingshead HE; Killins RL; Borland MG; Girroir EE; Billin AN; Willson TM; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Carcinogenesis; 2007 Dec; 28(12):2641-9. PubMed ID: 17693664
[TBL] [Abstract][Full Text] [Related]
20. Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammation.
Malm T; Mariani M; Donovan LJ; Neilson L; Landreth GE
J Neuroinflammation; 2015 Jan; 12():7. PubMed ID: 25592770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]